SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147S334.
  • 2
    Sibbald B. Epidemiology of allergic rhinitis. Monogr Allergy 1993;31:6179.
  • 3
    Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991;46:895901.
  • 4
    Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989;19:5963.
  • 5
    Gregory C, Cifaldi M, Tanner LA. Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population. Am J Manag Care 1999;5:485496.
  • 6
    Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108:S45S53.
  • 7
    Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182188.
  • 8
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:7783.
  • 9
    Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185189.
  • 10
    Vuurman EF, Van Veggel LM, Sanders RL, Muntjewerff ND, O'Hanlon JF. Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996;76:247252.
  • 11
    Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999;41:948953.
  • 12
    Blanc PD, Trupin L, Eisner M et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001;54:610618.
  • 13
    Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:38.
  • 14
    European Allergy White Paper. Brussels: : UCB Institue of Allergy, 1997.
  • 15
    Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc 2000;21:713.
  • 16
    Sullivan SD, Weiss KB. Health economics of asthma and rhinitis. II. Assessing the value of interventions. J Allergy Clin Immunol 2001;107:203210.
  • 17
    Jackson R, Feder G. Guidelines for clinical guidelines. BMJ 1998;317:427428.
  • 18
    International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy 1994;49:134.
  • 19
    Van Cauwenberge P, Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. European Acad Allergol Clin Immunol Allergy 2000;55:116134.
  • 20
    Demoly P, Allaert F-A, Lecasble M, PRAGMA (Programme de Recherches Appliquées à la Gestion des Maladies Allergiques). ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002;57:546554
  • 21
    Crobach MJ, Hermans J, Kaptein AA, Ridderikhoff J, Petri H, Mulder JD. The diagnosis of allergic rhinitis: how to combine the medical history with the results of radioallergosorbent tests and skin prick tests. Scand J Prim Health Care 1998;16:3036.
  • 22
    Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:16241629.
  • 23
    Nash DB, Sullivan SD, Mackowiak J. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting. Am J Manag Care 2000;6(1. Suppl):S315;S19–20(quiz).
  • 24
    Berger WE, Fineman SM, Lieberman P, Miles RM. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups. Ann Allergy Asthma Immunol 1999;82:535541.
  • 25
    Lund V, Van Cauwenberge P, Bousquet J, El Akkad T. Do the International Rhinitis Guidelines improve patients quality of life in seasonal allergic rhinitis? Allergy 2000 .
  • 26
    Juniper EF, Willms DG, Guyatt GH, Ferrie PJ. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. CMAJ 1992;147:887892.
  • 27
    Gawchik SM, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis. Am J Manag Care 1997;3:10521058.
  • 28
    Pedersen B, Dahl R, Richards DH et al. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy 1995;50:794799.
  • 29
    Brydon MJ. Understanding is the means to control. Management and treatment of seasonal rhinitis. Prof Nurse 1993;8:662666.
  • 30
    Gani F, Pozzi E, Crivellaro MA et al. The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy 2001;56:6568.
  • 31
    Camilleri AE. Information leaflets in the rhinitis clinic? J Laryngol Otol 1991;105:282284.
  • 32
    Johansson SGO, O'B Hourihane J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.